IAS for drugs
As a result of media requests regarding the functioning of the information and analytical system (IAS), the Ministry of Health of the Russian Federation and Roszdravnadzor report the following:
At the present time, as part of the improvements being made to the State Procurement System, the Ministry of Health of the Russian Federation together with interested federal authorities, has been developing a set of actions for moving over to reference pricing when procuring medical products, which should lead to greater efficiency and transparency of the procurement of medicines by stakeholders in the budget system of the Russian Federation.
As part of the implementation of the above-mentioned actions, a draft resolution “On features of describing medicinal products for medical use that are the subject of procurement” has been developed and brought before the Government of the Russian Federation. Adoption of the resolution will eliminate mistakes in the description of medicines in the procurement documentation and will harmonise this procedure, as well as reduce the propensity for corruption in the state procurement of medicines.
A draft of the order “On approval of the procedure for determining the initial (maximum) price of the contract, the price of the contract concluded with the sole supplier (contractor, executing agency), in the procurement of medicines for medical use” has been developed and is being approved by the Federal Anti-Monopoly Service of Russia. Publication of the this order will allow a procedure to be harmonised for calculating and justifying the initial (maximum) price of the contract, the price of the contract concluded with the sole supplier (contractor, executing agency) in procurement within the management of medicines for state and public needs.
The structure of the information contained in the unified guide-catalogue of medicines has been developed on the basis of the state register of medicinal products for medical use and the state register of the maximum selling prices set by manufacturers for medicinal products included in the list of vital and essential drugs that are handled in accordance with Federal Law No. 61-FZ “On the Management of Medicines” and from the outset not intended for structuring information in the information systems.
The information and analytical system has been in operation in trial mode since March, 1 2017. Since May, 29 2017 the government customers who participate in the procurement of medicines began entering information on concluded government contracts into the Uniform Information System in the field of procurements using structured information on procurement in accordance with the unified guide catalogue of medicines. At the present time, the Ministry of Health of the Russian Federation, together with the Federal Treasury and the state corporation Rostekh, is working on improving the guide via “feedback”, inter alia, with government customers.
According to preliminary estimates, introducing the calculation of the initial (maximum) price of the contract in accordance with the suggested Procedure has enabled Moscow to save about 10% of the total amount of financing intended to procure medicines (about 3 billion roubles).
It is planned before the end of 2017 to refine the interaction mechanisms between stakeholders in the procurement of medicines in order to prepare the start-up of the commercial operation of the information and analytical system from January 1, 2018.